This is also supported by interaction and stratified analyses showing that associations with CSF p-tau, t-tau, neurogranin, and NfL were only significant in A+ individuals, which suggests that weight loss in preclinical AD may occur mostly downstream to Aβ accumulation. This evidence concerns the gene MAPT and Alzheimer disease.